about
Plasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic AreasEvolutionary dynamics of human Toll-like receptors and their different contributions to host defenseChloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in MadagascarDandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalpTetrameric and homodimeric camelid IgGs originate from the same IgH locus.Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from AfricaOrigins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screeningEffects of mefloquine use on Plasmodium vivax multidrug resistanceRapid 96-well plates DNA extraction and sequencing procedures to identify genome-wide transposon insertion sites in a difficult to lyse bacterium: Lactobacillus casei.Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcerEvolutionary genetic dissection of human interferons.Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria.Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.Plasmodium falciparum parasite population structure and gene flow associated to anti-malarial drugs resistance in Cambodia.Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.
P50
Q27861961-0562E104-8CFA-49D8-A843-68F2DAAD6F42Q28252291-EB4B96EC-618F-46E6-8556-CF97F3884356Q28475757-E8644678-C165-4034-808B-FDBA1A26EE4BQ31112711-B6D2C5D2-E9C1-4194-BE01-E6EA1099DEC6Q33353298-48425DE1-8FE0-48A0-B984-25EDF7EEC99FQ33817484-74A5DEBC-6128-4E3B-8F1D-6647B320D068Q33876441-698C2327-4E60-4870-A7DD-85301039FE6CQ34099217-20C0426A-BCD8-4382-A942-C72D211CDE2FQ34320936-36C153AD-DE39-4536-9249-ECC78A5C1FCCQ35227548-CF2E1323-BC2E-44FB-9570-433A392D75C5Q35608680-6038A141-0818-48D7-8CA9-9C848151D397Q35627683-A909A3B5-4A30-4972-BB59-BC89772922C7Q35689218-6711DCE4-4991-4A17-9500-0C6B7F4CEF78Q35961823-06C018F4-B20A-4EBC-9560-FBF14A796085Q36498859-96A12195-6E5F-409B-9D57-73D3E301DA06Q36970800-9CAE3D6C-4167-4540-ABD9-5C92DB938825Q36993444-DFF73AAF-F890-4CB2-974A-F20A9191EE70Q37006417-0B653E26-28D1-4F07-9E28-16179EA0F351Q37409916-62E359DB-58F6-451B-981A-184BFDB47285
P50
description
onderzoeker
@nl
name
Magali Tichit
@ast
Magali Tichit
@en
Magali Tichit
@es
Magali Tichit
@nl
Magali Tichit
@sl
type
label
Magali Tichit
@ast
Magali Tichit
@en
Magali Tichit
@es
Magali Tichit
@nl
Magali Tichit
@sl
prefLabel
Magali Tichit
@ast
Magali Tichit
@en
Magali Tichit
@es
Magali Tichit
@nl
Magali Tichit
@sl